Perrigo Company plc (PRGO) concluded trading on Thursday at a closing price of $27.2, with 0.45 million shares of worth about $12.36 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 7.55% during that period and on July 03, 2025 the price saw a loss of about -0.22%. Currently the company’s common shares owned by public are about 137.20M shares, out of which, 136.80M shares are available for trading.
Stock saw a price change of 2.37% in past 5 days and over the past one month there was a price change of 2.56%. Year-to-date (YTD), PRGO shares are showing a performance of 3.62% which increased to 5.80% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $23.14 but also hit the highest price of $30.93 during that period. The average intraday trading volume for Perrigo Company plc shares is 1.34 million. The stock is currently trading 1.78% above its 20-day simple moving average (SMA20), while that difference is up 2.89% for SMA50 and it goes to 3.84% higher than SMA200.
Perrigo Company plc (NYSE: PRGO) currently have 137.20M outstanding shares and institutions hold larger chunk of about 101.68% of that.
The stock has a current market capitalization of $3.74B and its 3Y-monthly beta is at 0.47. It has posted earnings per share of -$1.27 in the same period. It has Quick Ratio of 1.28 while making debt-to-equity ratio of 0.87. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PRGO, volatility over the week remained 2.43% while standing at 1.99% over the month.
Stock’s fiscal year EPS is expected to rise by 18.00% while it is estimated to increase by 8.08% in next year.
Coverage by Piper Sandler stated Perrigo Company plc (PRGO) stock as a Neutral in their note to investors on January 06, 2025, suggesting a price target of $27 for the stock. On September 24, 2024, Jefferies Resumed their recommendations, while on November 17, 2023, Piper Sandler Initiated their ratings for the stock with a price target of $37. Stock get a Buy rating from Canaccord Genuity on March 07, 2023.
